DailyDoctor Archive Specialties Get app
Back to the 25 September 2026 edition

Clinical update · 01 of 05

AGA practice advice on MetALD: count the grams, ask every year, and stage fibrosis in two steps

In steatotic liver disease, quantify alcohol in grams per week at every annual review, advise stopping, and stage fibrosis with FIB-4 then elastography.

An AGA Clinical Practice Update in Clinical Gastroenterology and Hepatology (22 September 2026) gives nine best practice advice statements on metabolic dysfunction- and alcohol-associated liver disease (MetALD) — steatotic liver disease with cardiometabolic risk and moderate alcohol intake. It is expert opinion from a literature review, without formal evidence grading.

MetALD is defined by about 140-350 g of alcohol a week in women and 210-420 g in men, ideally over three months or more. All patients with steatotic liver disease should have alcohol use assessed at diagnosis and at least annually, by interview, questionnaire or biomarkers, and be advised to stop drinking. Fibrosis should be staged with FIB-4 first and elastography or ELF for indeterminate or high results — with caution, because active drinking raises liver stiffness. Management includes diet, exercise, micronutrient replacement (folate, thiamine, vitamin D), cardiometabolic risk treatment and alcohol use disorder pharmacotherapy where needed. Resmetirom and semaglutide have not been studied in MetALD, and bariatric surgery is not advised.

For gastroenterologists and hepatologists, the practical shift is making alcohol quantification in grams a routine part of every steatotic liver assessment.

  • Record alcohol intake in grams per week for every patient with steatotic liver disease
  • Reassess alcohol use at least yearly, with AUDIT-C or biomarkers where history is uncertain
  • Stage fibrosis with FIB-4 first, then elastography or ELF for indeterminate or high scores
  • Interpret a high liver stiffness cautiously in a patient still drinking
  • Replace folate, thiamine and vitamin D, and treat alcohol use disorder with medication where indicated

Why it matters

It gives structured advice for the large group whose liver disease has both metabolic and alcohol drivers, who fall between existing guidelines.

Don't overread it

These are expert-opinion best practice statements without formal evidence grading.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

masldcirrhosisgicancerfunctionalupperGi

Tomorrow morning, before your first patient

One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app